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Oxidative Stress Affects Synaptosomal -Aminobutyric
Acid and Glutamate Transport in Diabetic Rats
The Role of Insulin
Ana I. Duarte,1,2 Maria S. Santos,1,2 Raquel Seic¸a,1,3 and Catarina R. Oliveira1,4
Evidence suggests that oxidative stress is involved in
the pathophysiology of diabetic complications and that
insulin has a neuroprotective role in oxidative stress
conditions. In this study, we evaluated the in vitro effect
of insulin in the susceptibility to oxidative stress and in
the transport of the amino acid neurotransmitters
-aminobutyric acid (GABA) and glutamate in a synap-
tosomal fraction isolated from male type 2 diabetic
Goto-Kakizaki (GK) rat brain cortex. The ascorbate/
Fe2-induced increase in thiobarbituric acid reactive
substances (TBARSs) was similar in Wistar and GK rats
and was not reverted by insulin (1 mol/l), suggesting
that other mechanisms, rather than a direct effect in
membrane lipid peroxidation, may mediate insulin neu-
roprotection. Diabetes did not affect GABA and gluta-
mate transport, despite the significant decrease in
membrane potential and ATP/ADP ratio, and insulin
increased the uptake of both GABA and glutamate in GK
rats. Upon oxidation, there was a decrease in the uptake
of both neurotransmitters and an increase in extrasyn-
aptosomal glutamate levels and in ATP/ADP ratio in GK
rats. Insulin treatment reverted the ascorbate/Fe2-
induced decrease in GABA accumulation, with a de-
crease in extrasynaptosomal GABA. These results
suggest that insulin modulates synaptosomal GABA
and/or glutamate transport, thus having a neuroprotec-
tive role under oxidizing and/or diabetic conditions.
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In humans and experimentally diabetic rats, oxida-tive stress–mediated damage seems to be involvedin the cause of diabetic complications (1). Thishypothesis is based on reports of increased genera-
tion of reactive oxygen species (ROS), decreased antioxi-
dant levels, and/or impaired generation of the reduced
forms of the antioxidants (2–4), leading to lipid, protein,
and DNA oxidation (5). Brain is one of the most important
targets for ROS, because of its high levels of polyunsatu-
rated fatty acids, high oxygen consumption, high content
in transition metals (e.g., Fe2), and poor antioxidant
defenses (6).
Several authors have shown that diabetes modifies the
levels of free amino acids (7,8) and the accumulation of
amino acid neurotransmitters. Vilchis and Salceda (8)
reported an increase in taurine and -aminobutyric acid
(GABA) uptake, whereas glycine and glutamate uptake
remained unaffected in diabetic rat retina and retinal
pigment epithelium. In a previous study performed in
6-month-old diabetic Goto-Kakizaki (GK) rat synapto-
somes, we demonstrated a diabetes-induced decrease in
glutamate accumulation, leading to the hypothesis that
diabetes modifies glutamate transport and increases neu-
ronal injury occurring under pathological conditions (3).
It has been widely accepted that peripherally synthe-
sized insulin can be transported into the brain via the
cerebrospinal fluid. However, recent molecular biological
evidence suggests that it can also be synthesized de novo
by neurons, because the presence of preproinsulin I and II
mRNA or insulin receptor mRNA was observed in cultured
neurons. Moreover, insulin immunoreactivity occurs in the
endoplasmic reticulum and Golgi apparatus in vivo (9,10).
In the central nervous system, insulin seems to play an
important role, particularly in the complications caused by
diabetes, involving the regulation of brain metabolism
(11,12), neuronal growth and differentiation (9,13), or
neuromodulation (13,14). Insulin may also protect against
brain damage induced by stress conditions, such as oxi-
dative stress or ischemia (12,15). Brain glucose utilization
and metabolism are essential to cognitive functions, and a
disturbance in both or in the desensitization of brain
insulin receptors may be involved in the intellectual de-
cline in Alzheimer’s disease and related neurodegenerative
disorders (16,17), in which excitotoxicity and oxidative
stress have been shown to occur (18).
GK rats are a nonobese animal model of type 2 diabetes,
produced by repeated selective breeding of Wistar nondi-
abetic rats, using glucose intolerance as a selective index
(19). In the present study, we evaluated the interactions
among abnormal glucose metabolism, preincubation with
insulin, and the accumulation of the amino acid neuro-
transmitters GABA and glutamate in synaptosomes iso-
lated from the cerebral cortex of GK diabetic rats under
oxidative stress conditions. The oxidant pair ascorbate/
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Fe2 was used to induce oxidative injury, and the extent of
lipid peroxidation was followed by measuring the thiobarbi-
turic acid reactive substances (TBARSs) production.
RESEARCH DESIGN AND METHODS
Male spontaneously diabetic GK rats (31.9  0.7 weeks of age) were obtained
from our local breeding colony (Animal Research Center Laboratory, Univer-
sity Hospitals, Coimbra, Portugal), established in 1995 with breeding couples
from the colony at the Tohoku University School of Medicine (Sendai, Japan;
courtesy of Dr. K.I. Susuki). Control animals were nondiabetic male Wistar
rats of similar age (28.2  1.4 weeks of age) obtained from the same colony.
Animals were kept under controlled light and humidity conditions, with free
access to powdered rodent diet (diet C.R.F. 20; Charles River, L’Arbilesle,
France) and water. Glucose tolerance tests were used as a selection index.
All chemicals used were of the highest grade of purity commercially
available. [3H]GABA (65 Ci/mmol) and L-[G-3H]glutamate (49 Ci/mmol) were
from Amersham International (Little Chalfont, U.K.).
Blood glucose level determination. Blood glucose levels were determined
immediately after the animals were killed, through the glucose oxidation
reaction, using a glucometer (Glucometer Elite; Bayer, Carnaxide, Portugal)
and compatible reactive tests.
Preparation of synaptosomes. Crude synaptosomes were prepared from
brain of male Wistar and GK rats, according to a preestablished method (20),
with some modifications. After animal decapitation, the whole cerebral
cortices were rapidly removed and homogenized in 10 vol of homogenization
medium (0.32 mol/l sucrose, 10 mmol/l HEPES, and 0.5 mmol/l EGTA-K,
buffered with Tris at pH 7.4). The homogenate was centrifuged at 1,000g for 5
min, and the synaptosomal fraction was isolated from the supernatant by
centrifugation at 12,000g for 10 min and then centrifuged again at 12,000g for
10 min in 10 ml of washing medium (0.32 mol/l sucrose, 10 mmol/l HEPES,
buffered at pH 7.4 with Tris). The white and fluffy synaptosome layer without
contaminant mitochondria (mitochondria free), was then resuspended, re-
spun, and resuspended in the sucrose medium at a protein concentration of
15–20 mg/ml, as determined by the biuret method (21). Experiments were
carried out within 3 h after synaptosomal fraction preparation.
Induction of oxidative stress. The oxidizing agents ascorbic acid and iron
(Fe2, ferrous sulfate) were used to induce oxidative stress (22). Synapto-
somes (1 mg/ml) were peroxidized by incubation for 15 min at 30°C in a
standard medium that contained (in mmol/l) 132 NaCl, 3 KCl, 1 MgCl2, 1
NaH2PO4, 1.2 CaCl2, 10 glucose, and 20 mmol/l HEPES adjusted to pH 7.4 with
Tris, supplemented with 0.8 mmol/l ascorbic acid and 2.5 mol/l Fe2.
Ascorbic acid and Fe2 solutions were prepared immediately before use and
protected from light. Similar experiments were carried out in the presence of
1 mol/l insulin, with synaptosomes preincubated for 15 min before the
addition of ascorbate/Fe2.
Evaluation of lipid peroxidation. The extent of lipid peroxidation was
determined by measuring TBARSs, using the thiobarbituric acid assay (23).
The amount of TBARSs formed was calculated using a molar extinction
coefficient of 1.56  105 (mol/l)1  cm1 and expressed as nanomoles of
TBARSs per milligram of protein.
Determination of [3H]GABA and [3H]glutamate uptake. The uptake of
[3H]GABA and [3H]glutamate was determined as previously described (24,25).
Synaptosomes (0.5 mg of protein/ml) were equilibrated at 30°C in a Na
medium that contained (in mmol/l) 125 NaCl, 3 KCl, 1.2 MgSO4, 1.2 CaCl2, 3
glucose, and 10 HEPES-Tris at pH 7.4 in the absence or presence of ascorbic
acid (0.8 mmol/l) plus Fe2 (2.5 mol/l). The same experimental procedure
was carried out in the presence or absence of 1 mol/l insulin, with
synaptosomes preincubated for 15 min before the addition of ascorbate/Fe2.
Amino-oxyacetic acid (10 mol/l) was included in all media when studying the
uptake of [3H]GABA to prevent GABA metabolism. After 15 min of incubation,
the uptake reaction was started by adding [3H]GABA (final concentration 0.5
mol/l, 0.25 Ci/ml) or [3H]glutamate (final concentration 10 mol/l, 49
Ci/mmol). Uptake was stopped at 10 min by rapid filtration of the samples (0.2
ml) under vacuum, through glass fiber filters (Whatman GF/B), followed by a
wash with 10 ml of the Na-containing glucose-free medium (washing
medium). The filters were placed in scintillation vials with 3 ml of scintillation
UniverSol cocktail (ICN, Irvine, CA), and radioactivity was counted in a liquid
scintillation analyzer Packard Tri-Carb 2500 TR. The quenching of radioactiv-
ity in the samples was corrected automatically by using an efficiency corre-
lation curve obtained for 3H-quenched standards by the external
standardization method. The results were presented as percentage of the
control, considering the mean of Wistar rat synaptosomes not treated with
ascorbate/Fe2 as 100%.
Fluorimetric determination of extrasynaptosomal levels of amino acids
after high-performance liquid chromatography separation. The extra-
synaptosomal levels of the amino acids GABA and glutamate were analyzed
fluorometrically after o-phthaldialdehyde/2-mercaptoethanol derivatization
and high-performance liquid chromatography (HPLC) separation, as de-
scribed by Sitges et al. (26), with some modifications. The amino acids were
separated by reverse-phase Gilson-ASTED HPLC system, composed of a
Spherisorb ODS column (particle size, 5 m; 150-mm long; 4.6 mm i.d.) at 25°C
and a Gilson model 121 fluorescence detector set at 340 nm (excitation
wavelength) and at 410 nm (emission wavelength). A linear gradient elution
program carried out over 30 min was applied for amino acid elution: eluent A
(30 mmol/l sodium acetate buffer [pH 6.8]) from 100 to 50%, and eluent B
(methanol) from 0 to 50%, with a flow rate of 2.5 ml/min. Amino acids were
detected as fluorescence derivatives after precolumn derivatization with
o-phthaldialdehyde/2-mercaptoethanol. The integration of the amino acid
peak area and further calculations were carried out by Gilson system
software, and quantification was allowed by running standard amino acids
solutions under the same conditions.
Synaptosomal membrane potential measurements. The synaptosomal
transmembrane potential (m) was monitored by evaluating the transmem-
brane distribution of tetraphenylphosphonium (TPP) with a TPP-sensitive
electrode prepared according to Kamo et al. (27), using a calomel electrode as
reference. Reactions were carried out in a chamber with magnetic stirring in
1 ml of Na medium that contained (in mmol/l) 125 NaCl, 3 KCl, 1.2 MgSO4,
1.2 CaCl2, 3 glucose, and 10 HEPES-Tris at pH 7.4. Synaptosomes (0.5 mg/ml)
were equilibrated in Na medium for 15 min at 30°C in the absence or
presence of 1 mol/l insulin and then incubated for the same time with or
without ascorbate/Fe2. The experiments were started by adding 3 mol/l
TPP, and the membrane potential was estimated from the decrease in TPP
concentration in the reaction medium.
Determination of adenine nucleotides (ATP and ADP). At the end of the
	m measurements, each synaptosomal suspension was rapidly centrifuged at
14,000 rpm for 2 min with 0.3 mol/l perchloric acid. The supernatants were
neutralized with 10 mol/l KOH in 5 mol/l Tris and centrifuged at 14,000 rpm for
2 min. The resulting supernatants were assayed for adenine nucleotides by
separation in a reverse-phase HPLC, as described by Stocchi et al. (28). The
chromatographic apparatus used was a Beckman-System Gold, consisting of
a 126 Binary Pump Model and 166 Variable UV detector, controlled by a
computer. The detection wavelength was 254 nm, and the column used was a
Lichrospher 100 RP-18 (5 m) from Merck (Darmstadt, Germany). An
isocratic elution with 100 mmol/l phosphate buffer (KH2PO4; pH 6.5) and 1.0%
methanol was performed with a flow rate of 1 ml/min. The required time for
each analysis was 6 min. Peak identity was determined by the retention time
compared with standards. The amounts of ATP and ADP were determined by
a concentration standard curve, and the results were presented as percentage
of the control, considering the mean of Wistar rat synaptosomes not treated
with ascorbate/Fe2 as 100%.
Data analysis and statistics. Results are presented as mean  SE of the
indicated number of experiments. Statistical significance was determined
using the t test or the one-way ANOVA test for multiple comparisons. P
 0.05
was considered significant.
RESULTS
General characterization of GK rats. When the rats
were killed, blood glucose levels were significantly higher
in the diabetic GK group (241.8  26.5 mg/dl) as compared
with control Wistar rats (93.5  5.1 mg/dl).
Synaptosomal susceptibility to oxidative stress in-
duced by ascorbate/Fe2. Oxidative stress was induced
after 15 min of synaptosomal incubation with 0.8 mmol/l
ascorbate and 2.5 mol/l Fe2. Under these conditions, an
increase in lipid peroxidation, as determined by the for-
mation of TBARS, has been reported (3,4,15). In the
absence of ascorbate/Fe2, synaptosomal levels of TBARS
were similar in both Wistar and GK rats (2.6  0.3 and
2.7  0.2 nmol/mg protein, respectively; Fig. 1). In GK rat
synaptosomes, insulin did not significantly change TBARS
levels (2.7  0.2 and 2.6  0.3 nmol/mg protein in the
absence and in the presence of insulin, respectively).
Moreover, an 8.7-fold increase in TBARS formation in-
duced by ascorbate/Fe2 was observed and was not
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reverted by preincubation with insulin (24.2  2.3
nmol/mg protein).
Effect of insulin on the uptake of [3H]GABA and
[3H]glutamate under oxidative stress conditions. Un-
der nonoxidant conditions, [3H]GABA uptake was similar
in Wistar and GK rats, and preincubation with insulin
increased [3H]GABA uptake in GK rat synaptosomes, to
136  13.7% of Wistar controls under nonoxidant condi-
tions (Fig. 2A). The presence of ascorbate/Fe2 induced a
90% decrease in [3H]GABA uptake in GK rat synapto-
somes, which was almost completely prevented by prein-
cubation with insulin.
Under nonoxidizing conditions, there were no signifi-
cant differences in synaptosomal [3H]glutamate accumula-
tion between Wistar and GK rats. Insulin incubation
increased [3H]glutamate uptake in diabetic rats by 23%
(Fig. 2B). Ascorbate/Fe2 treatment decreased [3H]gluta-
mate uptake to 48.0  9.8% of Wistar control rat synapto-
somes. However, the protective effect of insulin was lower
compared with that seen in [3H]GABA. Under nonoxidiz-
ing conditions, the synaptosomal accumulation of
[3H]GABA and [3H]glutamate in Wistar rat synaptosomes
was 118.7 pmol/mg protein and 0.8 nmol/mg protein,
respectively.
Effect of oxidative stress and/or insulin on the extra-
synaptosomal levels of GABA and glutamate. In the
absence of ascorbate/Fe2, extrasynaptosomal GABA lev-
els were similar in both normal and diabetic rats (9.2 0.6
and 8.9  1.2 nmol GABA/mg protein, respectively; Fig.
3A), and insulin (1 mol/l) treatment did not affect its
levels in GK rat synaptosomes. In these animals, ascor-
bate/Fe2-induced oxidation increased 1.2-fold the extra-
synaptosomal levels of GABA, which was prevented by
insulin treatment (5.3  0.6 nmol GABA/mg protein).
Under control conditions, extrasynaptosomal levels of
glutamate were similar in Wistar and GK rats (17.8  0.4
and 16.4  1.2 nmol glutamate/mg protein, respectively),
and incubation with insulin did not affect the extrasynap-
tosomal content of glutamate in diabetic rats (Fig. 3B).
Upon oxidizing conditions, a 1.8-fold increase in extracel-
lular glutamate levels was observed, which was not pre-
vented by insulin.
Effect of oxidative stress and/or insulin on synapto-
somal m. Synaptosomal m was significantly lower
in diabetic rats relative to normal Wistar rat synapto-
somes (101.8 4.7 and80.4 7.7 mV in Wistar and GK
rat synaptosomal membranes, respectively). Insulin (1
mol/l) incubation did not significantly affect GK rat
FIG. 1. Effect of oxidative stress induced by ascorbate/Fe2 on the
extent of lipid peroxidation on synaptosomes isolated from GK rat
brain. Synaptosomes were preincubated in Na medium for 15 min at
30°C in the absence or in the presence of 1 mol/l insulin and then
incubated in the absence (nonoxidized) or in the presence (oxidized)
of 0.8 mmol/l ascorbate and 2.5 mol/l Fe2 for 15 min. The extent of
lipid peroxidation was evaluated by determining the production of
TBARSs and expressed as nmol/mg protein. Results obtained for Wistar
rat synaptosomes submitted or not to oxidative stress are also repre-
sented. Data are the means  SE of five to seven independent exper-
iments. ***P < 0.001 vs. the respective control (Wistar or GK rat
synaptosomes) not treated with ascorbate/Fe2; ###P < 0.001 vs. GK
rat synaptosomes treated with 1 mol/l insulin in the absence of
oxidizing conditions.
FIG. 2. Effect of insulin on the uptake of [3H]GABA (A) and [3H]glutamate (B) by GK rat synaptosomes submitted (oxidized) or not (nonoxidized)
to oxidative stress induced by ascorbate/Fe2. Synaptosomes were equilibrated in Na medium for 15 min at 30°C in the absence or in the
presence of 1 mol/l insulin and then incubated for 15 min with or without ascorbate/Fe2. Results obtained for Wistar rat synaptosomes
submitted or not to oxidative stress are also presented. Data, expressed as a percentage of [3H]GABA uptake or [3H]glutamate uptake in Wistar
control rat synaptosomes (considering 137.9 pmol [3H]GABA/mg protein and 0.7 nmol [3H]glutamate/mg protein as 100%), are the means  SE
of three to six and of three to seven different experiments, respectively. *P < 0.05; **P < 0.01; ***P < 0.001 vs. the respective control (normal
or diabetic rat synaptosomes) not treated with ascorbate/Fe2; #P < 0.05; ###P < 0.001 vs. GK rat synaptosomes treated with 1 mol/l insulin
in the absence of ascorbate/Fe2; ££P < 0.01 vs. synaptosomes from GK rats submitted to oxidizing conditions.
DIABETES INSULIN, AND OXIDATIVE STRESS
2112 DIABETES, VOL. 53, AUGUST 2004
synaptosomal m. In these rats, neither ascorbate/Fe
2
nor insulin treatment under oxidizing conditions signifi-
cantly altered m values (Fig. 4).
Effect of oxidative stress and/or insulin on synapto-
somal ATP/ADP ratio. The effects of insulin and/or
ascorbate/Fe2 treatment on the synaptosomal ATP/ADP
ratio are represented in Fig. 5. In the absence of oxidizing
conditions, the ATP/ADP ratio was significantly lower in
diabetic rats relative to normal Wistar rats, and synapto-
somal incubation with 1 mol/l insulin did not significantly
change this value. Under oxidizing conditions, diabetic rats
showed a 1.7-fold increase in the ATP/ADP ratio, which
was not altered upon insulin incubation. The ATP/ADP
ratio in Wistar rat synaptosomes under nonoxidizing con-
ditions was 2.9  0.9.
DISCUSSION
Nonenzymatic glycation and irreversible protein cross-
linking that occur under hyperglycemia may result in the
formation of advanced glycation end products and ROS
(29,30), supporting the idea that the increase in blood
FIG. 3. Effect of insulin on the release of the endogenous amino acids GABA (A) and glutamate (B) by GK rat synaptosomes submitted (oxidized)
or not (nonoxidized) to oxidative stress induced by ascorbate/Fe2. Results obtained for Wistar rat synaptosomes submitted or not to oxidative
stress are also presented. The values, expressed in nmol/mg protein, are the mean  SE of three to five independent experiments. *P < 0.05 vs.
the respective control (Wistar or GK rat synaptosomes) not treated with ascorbate/Fe2; #P < 0.05 vs. GK rat synaptosomes preincubated with
insulin. £P < 0.05 vs. GK rat synaptosomes upon oxidative stress conditions.
FIG. 4. Effect of insulin on the m in GK rat synaptosomes submitted
(oxidized) or not (nonoxidized) to oxidative stress induced by ascor-
bate/Fe2. Synaptosomes were equilibrated in Na medium for 15 min
at 30°C in the absence or in the presence of insulin and then incubated
for 15 min with or without ascorbate/Fe2. Membrane potential was
determined by following the decrease of TPP in the medium. Results
obtained for Wistar rat synaptosomes submitted or not to oxidative
stress are also presented. Data, expressed asmV, are the means SE
of 9–13 different experiments. *P < 0.05 vs. the respective control
(Wistar or GK rat synaptosomes) not treated with ascorbate/Fe2; #P
< 0.05 vs. the GK rat synaptosomes preincubated with 1 mol/l insulin
in the absence of oxidizing conditions.
FIG. 5. Effect of insulin in the ATP/ADP ratio in GK rat synaptosomes
submitted (oxidized) or not (nonoxidized) to oxidative stress induced
by ascorbate/Fe2. After the m measurements, each synaptosomal
suspension was treated with 0.3 mol/l perchloric acid and the superna-
tants were neutralized with 10 mol/l KOH in 5 mol/l Tris. Results
obtained for Wistar rat synaptosomes submitted or not to oxidative
stress are also presented. Data, expressed as a percentage of the
ATP/ADP ratio in Wistar control rat synaptosomes (considering 2.9 
0.9 as 100%), are the means  SE of 9–13 different experiments.
***P < 0.001 vs. the respective control (Wistar or GK rat synapto-
somes) not treated with ascorbate/Fe2; ###P < 0.001 vs. the GK rat
synaptosomes preincubated with 1 mol/l insulin in the absence of
oxidizing conditions.
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glucose levels (3,31) may render diabetic rats exposed to
oxidative stress (5,29).
Aberrant synaptic signaling has been implicated in neu-
rodegenerative disorders, such as Alzheimer’s disease
(32). Synaptosomes isolated from mammalian brain con-
stitute a useful in vitro model to study several nerve
functions, because they are metabolically active and retain
many properties of nerve endings, namely neurotransmit-
ter uptake (33,34).
In previous studies (3,4), we observed that GK rat brain
synaptosomes were less susceptible to ascorbate/Fe2-
induced oxidative stress than Wistar rats, suggesting a
protective mechanism against ROS-induced damage. In
the present study, we found that basal levels of TBARS
were similar in both animal models, as previously reported
(35). Our recent observation that insulin did not reverse
the ascorbate/Fe2-induced increase in TBARS levels in
Wistar rats suggests that other mechanisms, rather than a
direct action of insulin on lipid peroxidation, may mediate
its neuroprotective role under stress conditions (15).
The controversial observations reported by some au-
thors on alterations in brain amino acid transport using
diabetic rats may be related to the diabetic model or to the
experimental approach used. Morrison et al. (36) reported
that streptozotocin-induced diabetes (a type 1 diabetes
model) does not change the transport mechanism or the
receptor sensitivity to GABA. Li et al. (37) reported an
increased accumulation of extracellular glutamate in the
neocortex submitted to hyperglycemic ischemia, which
was correlated with the cell damage observed. In this
study, we reported that diabetes had no effect on both
synaptosomal GABA and glutamate transport, which is
partially in accordance with the observations of Vilchis
and Salceda (8). These authors demonstrated an incre-
ment in GABA uptake, without changes in glutamate
uptake in diabetic rat retina and retinal pigment epithe-
lium. These observations suggest that the modification of
transmembrane electrical gradient may affect the accumu-
lation of amino acid neurotransmitters. Our observation of
a diabetes-related decrease in both synaptosomal trans-
membrane gradient (m) and ATP/ADP ratio, resulting
from a decrease in ATP and/or an increase in ADP levels
(data not shown), further supports this hypothesis. The
decrease in ATP production is a hallmark of a disturbance
in glucose metabolism, which could be partially balanced
by the use of endogenous brain substrates, such as gluta-
mate and fatty acids (17). Synaptosomal uptake of neuro-
transmitters is an energy-dependent process that requires
the integrity of membrane systems (33) and functional
mitochondria. Thus, our observation of a diabetes-medi-
ated decrease in synaptosomal membrane potential and
ATP/ADP ratio suggests a glucose-dependent protective
mechanism in GK rat brain, with higher glucose levels
leading to the loss of the GABA-dependent protection
against glutamate neurotoxicity.
Our observation of an oxidative stress–induced de-
crease in synaptosomal GABA uptake, accompanied by an
increase in its extrasynaptosomal accumulation, sug-
gested that GK rats may have developed a protective
mechanism against oxidative stress–related neuronal
death (38,39). The decrease in glutamate uptake and
increased extrasynaptosomal levels induced by ascorbate/
Fe2 in GK rats further support this hypothesis, because
oxidative stress–induced damage to neuronal cell mem-
brane leads to the release and subsequent extracellular
accumulation of glutamate, contributing to excitotoxicity
(38) and further promoting ROS generation (40). Sah and
Schwartz-Bloom (41) reported that ROS-decreased inhibi-
tory neurotransmission also promotes neuronal damage in
oxidative stress–related diseases and aging. These effects
of oxidative stress on amino acid accumulation may be
due to membrane lipoperoxidation, which may impair the
GABA transporter, leading to a decrease of GABA accu-
mulation (42), and/or it may increase the release and
extracellular accumulation of aspartate and glutamate
(38,40). Other mechanisms that could be involved in the
inhibition of glutamate uptake by ROS may be the direct
oxidation of the transporter sulfhydryl groups (43,44) or
the impairment of Na,K ATPase activity (45).
The modulatory effect of insulin on amino acid accumu-
lation in brain remains controversial (14,46). In some
studies, 3 mol/l insulin stimulated glutamate and GABA
accumulation in rat brain synaptosomes (14), whereas in
others, the same concentration was shown to inhibit
GABA uptake in embryonic chick retina and newborn
mouse cerebral cortex astroglial cells (11,47). According
to Rhoads et al. (14), insulin dose-dependently stimulates
synaptosomal amino acid uptake, and 1 mol/l was the
lowest insulin concentration that increased glutamate
uptake by cortical synaptosomes, by an effect maintained
during 1–20 min of in vitro incubation. In the present
study, we used an insulin concentration of 1 mol/l,
incubated for 15 min with the synaptosomal fraction, in
the absence or presence of the oxidizing pair ascorbate/
Fe2. In a recent article, we reported that, in Wistar rat
synaptosomes, insulin reverted both the oxidative stress–
related inhibition in the uptake and the increase in GABA
and glutamate extrasynaptosomal accumulation (15).
In this study, we observed that 1 mol/l insulin per se
stimulated intrasynaptosomal GABA accumulation in dia-
betic rat brain synaptosomes, suggesting that the neuro-
protective role of insulin may be exerted directly on
membrane GABA transporters. Some authors (11,14) hy-
pothesized that insulin-induced changes in GABA trans-
port can be exerted indirectly through the stimulation of
Na,K ATPase activity, thus increasing the transmem-
brane Na gradient and the m. However, Guyot et al.
(48) postulated that these changes could be related to
stimulation of glycolysis and pyruvate dehydrogenase,
increasing lactate and ATP levels, which stimulate ion
pumps and, ultimately, the synaptosomal amino acid trans-
port. Our results did not show insulin-induced changes in
m or ATP/ADP ratio, suggesting that the increase in the
uptake of both GABA and glutamate might be related to a
direct effect of insulin in both amino acid transporters.
However, the activation of insulin receptor signaling cas-
cade via its tyrosine kinase activity, which activates the
uptake of amino acids (49), cannot be ruled out. We also
observed that insulin reverted the effect of ascorbate/Fe2,
increasing GABA uptake and decreasing its extrasynapto-
somal levels, supporting the idea of a neuroprotective role
for insulin. This hypothesis is also supported by a nonsig-
nificant decrease in extrasynaptosomal glutamate levels
observed under these conditions.
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Recent evidence suggests that a dysfunction of the
neuronal insulin receptor signaling cascade, with the sub-
sequent abnormalities in glucose/energy metabolism, may
affect amyloid precursor protein metabolism and induce 
hyperphosphorylation. These results suggest that insulin
dysfunction could be involved in the cause of Alzheimer’s
disease (12,17) and supports the hypothesis of a neuropro-
tective role of insulin under stress conditions. The data
obtained in the present study support the idea that a direct
effect on amino acid neurotransmitter transport system
(mainly GABA) could be one of the mechanisms respon-
sible for the neuroprotective role of insulin in oxidative
stress conditions, suggested to occur in diabetes and
neurodegenerative diseases.
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